NKGen Biotech

NKGen Biotech EPS

The Earnings per Share (EPS) of NKGen Biotech (NKGN) as of Oct 9, 2026 is -1.54 USD. In the previous year, Earnings per Share (EPS) was -3.79 USD — a change of -59.47% (higher).

EPS

-1.54USD

YoY

-59.47%

Last updated:

Earnings per Share (EPS) of NKGen Biotech is 2025 -1.54 USD. Earnings per Share (EPS) of NKGen Biotech was 2024 -3.79 USD. It decreases by -59.47% higher compared to the previous year.

The NKGen Biotech EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2021
-1.08 USD
Jan 1, 2022
-1.25 USD
Jan 1, 2023
-3.79 USD
Jan 1, 2025
-1.54 USD
The NKGen Biotech EPS history
YEAREPSYoY
-1.54USD-59.47%
-3.79USD+203.87%
-1.25USD+15.00%
-1.08USD—
Access this data via the Eulerpool API
Get Free API Key

NKGen Biotech Stock analysis

What does NKGen Biotech do? NKGen Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about NKGen Biotech stock

Earnings per Share (EPS) of NKGen Biotech is -1.54 USD in 2025.

Earnings per Share (EPS) of NKGen Biotech changed from -3.79 USD to -1.54 USD, representing a -59.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) NKGen Biotech since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API
Get Free API Key

Income Statement — NKGen Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — NKGen Biotech